Italy · Edizioni Minerva Medica S.p....

workspace_premium Q3 — Obstetrics and Gynecology lock Subscription

Minerva Ginecologica

Minerva Ginecologica is a journal indexed in SJR in Obstetrics and Gynecology with an H index of 33. It has a price of 2395 €. It has a best quartile of Q3. It is published in English.

ISSN: 0026-4784

Publisher: Edizioni Minerva Medica S.p.A.

Category: Obstetrics and Gynecology

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

NPD Q3

H-index 33

Acceptance rate pie_chart

35%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.395 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

SJR Impact

—

H-index

Docs (year)

Docs 3y

209

Total refs

Cites 3y

349

Citable 3y

167

Cites/Doc 2y

1.24

Ref/Doc

56.0

Immediate OA

2395 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Contraception with the new intrauterine systems: a winning choice if shared!

Which factors make the difference in the progression of cervical dilation in vaginal birth after cesarean section?

Effects of adenomyosis on obstetric outcomes

Effectiveness, quality of life and sexual functions in women with anterior compartment prolapse treated by native tissue repair

Dyslipidemia in pregnancy and maternal-fetal outcome

Duration of ovarian stimulation is predictive of in-vitro fertilization outcomes

Double stimulation in the same ovarian cycle (DuoStim) is an intriguing strategy to improve oocyte yield and the number of competent embryos in a short timeframe

Does supraphysiologic estradiol level during IVF have any effect on oocyte/embryo quality? A sibling embryo cohort analysis of fresh and subsequent frozen embryo transfer

Does hysterosalpingo-foam sonography have any therapeutic effect? A systematic review

Cumulative live birth rates in in-vitro fertilization

Crosstalk between gonadotropins and thyroid axis

Criteria, phenotypes and prevalence of polycystic ovary syndrome

SHOW MORE ARTICLES

Correction to: Joint recommendations for the diagnosis and treatment of vulvo-vaginal atrophy in women in the peri- and post-menopausal phases from the Societa Italiana per la Menopausa (SIM) and the Societa Italiana della Terza Eta (SIGiTE)

A preliminary magnetic resonance spectroscopy study of postmenopausal hormone effects on the brain

Comparison of patients' reported pain following office hysteroscopy with and without endometrial biopsy: a prospective study

Combination of weekly topotecan and gemcitabine as a salvage treatment in patients with recurrent ovarian cancer: a phase I study

Circulating visfatin levels in the second and third trimester of pregnancies with gestational diabetes: a systematic review

beta-arrestins and biased signaling in gonadotropin receptors

Assisted reproductive technique in women of advanced fertility age

Assessment of non-gynecological symptoms before and after removal of the Essure¬Æ sterilization device: a 6-month follow-up study

Application of failure mode and effect analysis in total laparoscopic hysterectomy in benign conditions

Anti-Mullerian hormone (AMH) regulates stemness-promoting factors in fresh and previously vitrified-warmed ovarian cortex

An open trial of a Visnadine emulgel topical application in postmenopausal superficial dyspareunia: daily vs. on-demand use

An innovative approach to evaluate preeclampsia risk in the first trimester of pregnancy

FAQs

SJR is not available (NPD) for Minerva Ginecologica in the CountryOfPapers database.

Immediate OA APC is 2395 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Minerva Ginecologica is 35%.

Minerva Ginecologica

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Minerva Ginecologica?

What is the APC / publication cost?

What is the acceptance rate?